V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310008520 | 310005693 | null | 74.6 | Disease modification (D) | null | 2016-08-16 | IVAC | N | N | 310003715 | PEG INTERFERON |
| 310008521 | 310005697 | 1.84 | null | Curative (C) | null | 2018-11-14 | PEG INTERFERON | 2 | N | 310003778 | CARBOPLATIN + ETOPOSIDE + THIOTEPA |
| 310008522 | 310005698 | null | null | Not known (9) | 2019-02-02 | 2019-02-02 | Bevacizumab+Carbo+Gemcitabine | null | null | 310005478 | CISPLATIN + FLUOROURACIL |
| 310008523 | 310005699 | null | 74.1 | Curative (C) | 2015-07-15 | 2015-07-26 | BENDAMUSTINE + RITUXIMAB | 02 | N | 310007819 | IRINOTECAN + MDG |
| 310008524 | 310005700 | 1.8 | null | Curative (C) | 2017-08-22 | 2019-02-17 | Capecitabine (21days) + Carboplatin | 2 | N | 310010646 | SUNITINIB |
| 310008525 | 310005702 | null | 65.1 | Curative (C) | 2018-09-27 | 2018-10-08 | DABRAFENIB + TRAMETINIB | 02 | N | 310010899 | CEV |
| 310008526 | 310005704 | 1.72 | 56.7 | Neo-adjuvant (N) | 2017-03-09 | 2017-03-28 | Capecitabine (21 day) + Irinotecan | 02 | N | 310011301 | IRINOTECAN + MDG |
| 310008527 | 310005705 | 1.83 | 86 | Palliative (P) | 2018-05-27 | 2018-09-28 | DOXORUBICIN | 02 | N | 310011301 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE |
| 310008528 | 310005707 | 1.6 | 50 | Disease modification (D) | 2017-05-06 | 2017-05-08 | Oxaliplatin + Modified de Gramont | N | N | 310013605 | SUNITINIB |
| 310008529 | 310005707 | 1.54 | 54.9 | null | 2015-07-18 | 2015-11-20 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | N | null | 310013605 | HYDROXYCARBAMIDE |
| 310008530 | 310005707 | 0.6 | 71.3 | Palliative (P) | null | 2017-01-25 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE | N | N | 310013605 | CERITINIB |
| 310008531 | 310005708 | null | null | Palliative (P) | 2015-11-13 | 2015-12-25 | Trastuzumab Subcutaneous | N | N | 310016083 | METHOTREXATE |
| 310008532 | 310005711 | 1.73 | 74.6 | Palliative (P) | 2018-09-26 | 2018-10-19 | NIVOLUMAB | 02 | N | 310016083 | LENALIDOMIDE |
| 310008533 | 310005714 | 1.64 | null | Palliative (P) | 2018-01-31 | 2018-02-01 | Erlotinib | 2 | N | 310020507 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 310008534 | 310005715 | 1.76 | 0 | Neo-adjuvant (N) | 2017-11-12 | 2017-12-13 | CHLVPP | N | N | 310020717 | BENDAMUSTINE |
| 310008535 | 310005717 | null | 50 | Palliative (P) | 2018-04-08 | 2018-04-21 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 310021650 | CVP |
| 310008536 | 310005718 | null | null | Adjuvant (A) | 2017-05-04 | 2017-06-02 | UKALL14- Ph 2 Induction | 2 | N | 310021650 | CISPLATIN + FLUOROURACIL |
| 310008537 | 310005719 | 1.75 | 77.4 | Palliative (P) | 2016-05-29 | 2016-07-12 | Ifosfamide | N | N | 310022131 | IRINOTECAN + MDG |
| 310008538 | 310005720 | 1.51 | 80.5 | Not known (9) | null | 2016-09-10 | Cyclophosphamide Fludarabine (Oral) | 2 | N | 310023683 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 310008539 | 310005721 | 1.6 | 0 | null | 2015-06-18 | 2015-07-20 | CAPECITABINE + CISPLATIN + EPIRUBICIN | N | null | 310023817 | DABRAFENIB + TRAMETINIB |
| 310008540 | 310005722 | null | 49.8 | null | 2016-09-21 | 2016-09-21 | EOX | N | N | 310024088 | OLAPARIB |
| 310008541 | 310005723 | 1.69 | 12 | null | 2015-07-16 | 2015-07-16 | Vinblastine | N | N | 310024186 | CAPECITABINE + OXALIPLATIN |
| 310008542 | 310005724 | 1.74 | 81 | Curative (C) | 2018-11-18 | 2018-11-18 | PMitCEBO | 02 | N | 310024427 | SELPAC TRIAL |
| 310008543 | 310005725 | 1.75 | 72.9 | Palliative (P) | 2016-09-17 | 2019-02-02 | Alemtuzumab cond (RI ALLO CAMP100) | 02 | N | 310024427 | ICE |
| 310008544 | 310005726 | 1.69 | 107.9 | Palliative (P) | 2016-07-19 | 2016-07-28 | Gemcitabine + Oxaliplatin | 2 | N | 310025128 | ATEZOLIZUMAB |
| 310008545 | 310005727 | 1.75 | 117.5 | Curative (C) | 2015-12-21 | 2015-12-26 | Lenalidomide Cycle 26 onwards (PAS) | 02 | N | 310025709 | DACARBAZINE |
| 310008546 | 310005728 | null | 52 | Palliative (P) | 2019-04-19 | 2019-05-20 | Methotrexate High Dose (3g/m2) | N | N | 310004470 | ECHELON-2 TRIAL |
| 310008547 | 310005728 | 1.58 | 54.7 | null | 2016-06-08 | 2016-06-10 | Ifosfamide | 02 | N | 310004470 | CARBOPLATIN + RT |
| 310008548 | 310008551 | 1.74 | 118 | Adjuvant (A) | 2018-10-28 | 2018-11-17 | CARBOPLATIN + FLUOROURACIL | 02 | N | 310019348 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310008549 | 310010883 | null | null | Palliative (P) | 2018-03-28 | 2018-03-28 | CHOEP | 2 | N | 310020717 | ALEMTUZUMAB |
| 310008550 | 310010883 | 1.73 | null | Curative (C) | 2015-10-05 | 2015-11-28 | CISPLATIN + ETOPOSIDE | N | N | 310020717 | BCG |
| 310008551 | 310011764 | null | 92.5 | Curative (C) | 2016-11-12 | 2016-12-02 | CRIZOTINIB | 2 | N | 310024445 | BCG |
| 310008552 | 310005731 | 1.79 | 54.2 | null | 2019-05-24 | 2019-11-01 | CARBOPLATIN + RT | null | N | 310024445 | IVA |
| 310008553 | 310010063 | 1.7 | 65.5 | Adjuvant (A) | 2018-10-22 | 2018-10-30 | Hydroxycarbamide | N | N | 310002808 | R-HYPER-CVAD |
| 310008554 | 310008554 | 1.63 | 151.6 | Curative (C) | 2018-08-15 | 2018-08-15 | Hydroxycarbamide | 02 | N | 310003015 | CARBOPLATIN + PEMETREXED |
| 310008555 | 310008555 | 1.73 | null | Not known (9) | 2017-03-12 | 2017-03-23 | NB BEACON Temozolomide Bevacizumab | N | N | 310003166 | CAPECITABINE |
| 310008556 | 310002693 | 1.63 | 49.4 | Palliative (P) | 2017-03-14 | 2017-04-01 | Carboplatin AUC 2 - 5 | N | N | 310000272 | CARBOPLATIN |
| 310008557 | 310002694 | 1.61 | 102.4 | Palliative (P) | 2017-07-25 | 2017-08-03 | Paclitaxel 7 day | N | N | 310000365 | PACLITAXEL |
| 310008558 | 310002696 | 1.57 | 65 | Palliative (P) | 2015-07-05 | 2015-07-19 | Carboplatin AUC 6 - 10 | N | N | 310000978 | CARBOPLATIN |
| 310008559 | 310002701 | 1.55 | 75.6 | null | 2014-02-23 | 2014-03-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 310003932 | CARBOPLATIN + PACLITAXEL |
| 310008561 | 310002702 | 1.81 | 46.4 | Neo-adjuvant (N) | 2013-09-06 | 2013-09-06 | Carboplatin 21day + Paclitaxel 7day | 02 | N | 310003947 | CARBOPLATIN + PACLITAXEL |
| 310008562 | 310002705 | 1.58 | 74.9 | Palliative (P) | 2017-04-09 | 2017-07-07 | CARBOPLATIN + PACLITAXEL | N | N | 310003952 | CARBOPLATIN + PACLITAXEL |
| 310008563 | 310007116 | 1.67 | 59.5 | null | null | 2014-12-03 | Carboplatin AUC 6 - 10 | N | N | 310003955 | CARBOPLATIN |
| 310008564 | 310002708 | 1.56 | 54.8 | Palliative (P) | 2016-01-25 | 2016-02-03 | Carboplatin AUC 2 - 5 | 02 | N | 310003961 | CARBOPLATIN |
| 310008565 | 310002710 | null | null | Palliative (P) | null | 2014-02-23 | CARBOPLATIN + PACLITAXEL | N | null | 310003971 | CARBOPLATIN + PACLITAXEL |
| 310008566 | 310002712 | 1.52 | 57.2 | Palliative (P) | 2017-05-05 | 2017-05-18 | Carboplatin AUC 6 - 10 | 2 | N | 310003972 | CARBOPLATIN |
| 310008567 | 310002715 | null | null | Palliative (P) | null | 2016-02-06 | PACLITAXEL | N | null | 310003988 | PACLITAXEL |
| 310008568 | 310002716 | 1.76 | 68.8 | Disease modification (D) | 2015-09-03 | 2015-11-12 | Carboplatin AUC 2 - 5 | 2 | N | 310004006 | CARBOPLATIN |
| 310008569 | 310002718 | 1.59 | 62 | Palliative (P) | 2018-01-03 | 2018-01-28 | Carboplatin + Paclitaxel (3 weekly) | N | N | 310004009 | CARBOPLATIN + PACLITAXEL |
| 310008570 | 310002723 | 1.8 | null | Palliative (P) | 2015-04-25 | 2015-05-13 | Carboplatin + Paclitaxel (3 weekly) | N | N | 310004023 | CARBOPLATIN + PACLITAXEL |